While standard models rely heavily on GLP-1 pathways alone, Retatrutides integration of GIP and Glucagon receptors creates a compounding effect
Ozempic (semaglutide) is a medication approved by the Food and Drug Administration (FDA) to treat type 2 diabetes
The model is async and patient-led
Liu W, Kelly JW, Trivett M, Murray WK, Dowling JP, Wolfe R, Mason G, Magee J, Angel C, Dobrovic A, McArthur GA
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Patients currently taking metformin who are considering compounded semaglutide options, injectable or oral semaglutide forms, should maintain open communication with their healthcare providers about their treatment goals and any concerns